Navigation Links
iCo Therapeutics Closes $1.3 Million Private Placement
Date:2/9/2009

acement. All securities issued in the private placement are subject to a four month hold period. The private placement is subject to regulatory approval, including the approval of the TSX Venture Exchange.

About iCo Therapeutics

iCo Therapeutics Inc. is a Vancouver-based reprofiling company focused on redosing or reformulating drugs with clinical history for new or expanded indications. iCo has exclusive worldwide rights to three products, iCo-007, in Phase I for the treatment of Diabetic Macular Edema, iCo-008, a product with Phase II clinical history to be developed for severe ocular allergies, and iCo-009, an oral formulation of Amphotericin B for sight and life - threatening diseases. iCo-009 also represents a new drug delivery technology with the potential to reprofile other parenteral administered drugs to the oral route of administration. iCo Therapeutics trades on the TSX-Venture exchange under the symbol "ICO". For more information, visit the company website at: www.icotherapeutics.com

    No regulatory authority has approved or disapproved the content of this
    release. The TSX Venture Exchange does not accept responsibility for the
    adequacy or accuracy of this release.

Forward Looking Statements

Certain statements included in this press release may be considered forward-looking. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements, and therefore these statements should not be read as guarantees of future performance or results. All forward-looking statements are based on iCo Therapeutics' current beliefs as well as assumptions made by and information currently available to iCo Therapeutics and relate to, among other things, anticipated financial per
'/>"/>

SOURCE iCo Therapeutics Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Cell Therapeutics, Inc. (CTI) BIO CEO Presentation to be Webcast
2. Amicus Therapeutics Announces Fourth Quarter and Full Year 2008 Financial Results
3. Sopherion Therapeutics, LLC Announces Publication of Phase I/II Myocet(R) (Nonpegylated Liposomal Doxorubicin) Data in Advanced Breast Cancer Patients
4. Cell Therapeutics Exchanges 83% of Remaining Convertible Preferred Stock Into New Non-dividend Bearing, Non-redeemable Convertible Preferred Stock With Conversion Price of $0.14 per Share
5. Orexigen(R) Therapeutics to Speak at BIO CEO & Investor Conference
6. Lentigen and Expression Therapeutics Sign Hemophilia Co-Development Agreement
7. Omnitura Therapeutics Announces Private Placement Financing
8. Amicus Therapeutics Announces Fourth Quarter and Year End 2008 Financial Results Release Date
9. Helsinn Announces the Acquisition of Sapphire Therapeutics Inc., USA to Establish Helsinn Therapeutics (US) Inc.
10. CV Therapeutics Statement on Unsolicited Proposal From Astellas
11. Cell Therapeutics Receives Additional NASDAQ Notification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... March 06, 2015 Global Specimen ... CRO focused on specimen management and informatics, announced ... “Global Specimen Solutions, Inc. is excited to catapult ... investment that will further enhance our proprietary informatics ... supporting specimen research. GSS has proved rapid market ...
(Date:3/6/2015)... Anton Paar has released an application ... laboratory refractometers. Sodium hydroxide (NaOH, also known as ... variety of products including pretzels, colored fabrics, soap and ... the chemical industry; its applications range from the food ... in between. NaOH is used in the production ...
(Date:3/5/2015)... , March 5, 2015  Twelve patients today ... kidney paired donation transplant at California Pacific Medical Center ... here believe this procedure will be the largest single-center ... and the largest conducted in the 44-year history of ... and tomorrow began with an altruistic donor who did ...
(Date:3/5/2015)... BioPlus Specialty Pharmacy (BioPlus) announces the hiring ... of Managed Care. In this role, Damm will build ... nation’s leading specialty pharmacies. , Damm, who is based ... pharmacy and biotech experience to his new position with ... and Pfizer. Prior to working in Healthcare Damm served ...
Breaking Biology Technology:Global Specimen Solutions, Inc. Closes Series A Funding 2Global Specimen Solutions, Inc. Closes Series A Funding 3Altruistic donor starts large West Coast single-center kidney paired donation at CPMC 2Altruistic donor starts large West Coast single-center kidney paired donation at CPMC 3Altruistic donor starts large West Coast single-center kidney paired donation at CPMC 4BioPlus Specialty Pharmacy Announces Hiring of New Vice President of Managed Care: Jamie Damm 2
... Laura Gaidar, Kristin Prasauckas, , ... PerkinElmer Life Sciences, Inc. , ... AlphaScreen technology is a highly sensitive, non-isotopic homogenous assay ... Sciences has developed two instruments for the detection of AlphaScreen reagents. The ...
... , ... N. Bobrow, Ph.D., PerkinElmer Life Sciences, Inc. , ... The use of DNA microarrays in scientific research and drug discovery has ... are the vast majority of the true drug targets, there has been ...
... Abstract , ... and Luminescence Counter has been widely used in biopharmaceutical assays ... the use of TopCount for measuring a high energy beta ... well-known measurement technique that has the main advantage of not ...
Cached Biology Technology:Comparison of Performance between the AlphaQuest - HTS and the Fusion α Multilabel Reader for Detection of cAMP 2Comparison of Performance between the AlphaQuest - HTS and the Fusion α Multilabel Reader for Detection of cAMP 3Comparison of Performance between the AlphaQuest - HTS and the Fusion α Multilabel Reader for Detection of cAMP 4New Tools for Making and Processing Protein Microarrays. 2New Tools for Making and Processing Protein Microarrays. 3New Tools for Making and Processing Protein Microarrays. 4New Tools for Making and Processing Protein Microarrays. 5New Tools for Making and Processing Protein Microarrays. 6New Tools for Making and Processing Protein Microarrays. 7New Tools for Making and Processing Protein Microarrays. 8New Tools for Making and Processing Protein Microarrays. 9Cerenkov Counting Performance on the TopCountTM Microplate Scintillation and Luminescence Counter 2Cerenkov Counting Performance on the TopCountTM Microplate Scintillation and Luminescence Counter 3Cerenkov Counting Performance on the TopCountTM Microplate Scintillation and Luminescence Counter 4Cerenkov Counting Performance on the TopCountTM Microplate Scintillation and Luminescence Counter 5Cerenkov Counting Performance on the TopCountTM Microplate Scintillation and Luminescence Counter 6Cerenkov Counting Performance on the TopCountTM Microplate Scintillation and Luminescence Counter 7
(Date:2/24/2015)... report analyzes the worldwide markets for Face and Voice Biometrics in ... The report provides separate comprehensive analytics for the US, ... , Asia-Pacific , Middle East ... Latin America . Annual estimates and forecasts are provided for ... provided for these markets. Market data and analytics are derived from ...
(Date:2/13/2015)... , Feb. 13, 2015 ACT ... company that aims to transform cancer genomic information ... that the company has raised US$ 8 million in ... Based in Taipei, Taiwan , ... ACTDrug™, ACTOnco™. With the aim to implement next ...
(Date:2/9/2015)... , Feb. 9, 2015  Lintec of America recently ... for carbon nanotube (CNT) macrostructures, including sheets, yarns and ... (UTD). Leveraging the vast industrial resources of ... Japan , Lintec of America is forming the ... TX , focusing on scaling up the manufacturing ...
Breaking Biology News(10 mins):World Face and Voice Biometrics Industry 2World Face and Voice Biometrics Industry 3World Face and Voice Biometrics Industry 4World Face and Voice Biometrics Industry 5World Face and Voice Biometrics Industry 6World Face and Voice Biometrics Industry 7World Face and Voice Biometrics Industry 8World Face and Voice Biometrics Industry 9World Face and Voice Biometrics Industry 10World Face and Voice Biometrics Industry 11World Face and Voice Biometrics Industry 12World Face and Voice Biometrics Industry 13World Face and Voice Biometrics Industry 14World Face and Voice Biometrics Industry 15World Face and Voice Biometrics Industry 16ACT Genomics Raises $8 Million in its First Private Funding Round 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4
... repetitive, gene-poor DNA found in regions of chromosomes ... matter in the universe, the true nature of ... the Drosophila Heterochromatin Genome Project (DHGP), headed by ... Berkeley National Laboratory, are approaching a complete assembly, ...
... Suppressing colony formation is a useful strategy against copepods because ... single-celled organism that plays a key role in the carbon ... scientists had suspected. , In a paper published June 11 ... of Sciences, researchers report the first evidence that a common ...
... parasite species that cause Leishmaniasis has identified a small ... provide a framework to target the search for new ... two million people each year and threatens one-fifth of ... , In their report in Nature Genetics, published ...
Cached Biology News:Exploring the dark matter of the genome 2Exploring the dark matter of the genome 3Exploring the dark matter of the genome 4Exploring the dark matter of the genome 5Exploring the dark matter of the genome 6Marine phytoplankton changes form to protect itself from different predators 2Marine phytoplankton changes form to protect itself from different predators 3Marine phytoplankton changes form to protect itself from different predators 4Potent possibilities for parasite attack 2Potent possibilities for parasite attack 3
... Gel loading buffer is especially formulated ... of nucleic acids. The gel loading solution ... sucrose to add density and facilitate sample ... nucleases that require divalent cations and SDS ...
... systems. , Integrated Instrument Control , ... EZChrom Elite can be configured with a ... provides a completely integrated system to control instrument's operation, collect andstore ... ...
Rabbit anti Xanthine Oxidase Xanthine Oxidase, Bovine Buttermilk...
... SilverSNAP Stain for Mass Spectrometry Applications ... spectrometry (MS) has emerged as a powerful ... of 2-D gels is now an important ... that leads ultimately to identification of specific ...
Biology Products: